Pfenex (PFNX) Tops Q2 EPS by 12c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. JNJ
6. PLTR
7. QQQ
8. LDOS
9. AXP
10. AON

Go back to Pfenex (PFNX) Tops Q2 EPS by 12c

Pfenex Reports Second Quarter 2015 Results and Provides Business Update

August 13, 2015 7:47 AM EDT

SAN DIEGO, Aug. 13, 2015 /PRNewswire/ -- Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high value and difficult to manufacture proteins, today reported financial results for the second quarter ended June 30, 2015 and provided a business update.

"Pfenex made significant progress in the second quarter of 2015, and we expect to provide key pipeline updates over the course of 2015 and into 2016.  Specifically, we look forward to updating you on progress... More